Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Singular Genomics Systems, Inc. is a life science technology company focused on developing and commercializing innovative next-generation sequencing (NGS) and multiomics technologies. Their mission is to empower researchers and clinicians with more accessible, flexible, and accurate genomic analysis tools. The company's flagship products include the G4 Sequencing Platform and the PX Integrated Solution, designed to offer speed, power, and flexibility for various applications in genomics research.
Serves as the central hub for research and development, manufacturing, corporate operations, and strategic decision-making.
Located in a prominent biotech cluster, the facility likely includes advanced research laboratories, clean rooms for manufacturing sensitive sequencing components, and collaborative workspaces designed to foster innovation.
The work culture at Singular Genomics likely emphasizes innovation, scientific rigor, collaboration, and a fast-paced environment driven by the pursuit of cutting-edge genomics technology. Employees are often passionate about advancing science and medicine.
The La Jolla headquarters is critical for Singular Genomics's ability to innovate in the competitive NGS market, attract top scientific talent, and manage its global operations and product development pipeline.
Singular Genomics primarily operates from its US-based facilities for R&D and manufacturing. However, it supports a global customer base through direct sales channels, distribution partners, and collaborations with research institutions worldwide. Their sequencing platforms and technologies are utilized by researchers internationally across various genomic applications.
10931 N Torrey Pines Rd, Suite 100
La Jolla
CA
USA
Address: 3900 Varsity Dr, Ann Arbor, MI 48108, USA
Expansion of R&D capabilities, access to a different talent market, and potentially closer collaboration with research institutions in the Midwest.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Singular Genomics' leadership includes:
Singular Genomics has been backed by several prominent investors over the years, including:
Singular Genomics has seen some key leadership transitions and appointments in the past 12-18 months focused on strengthening its commercial and operational capabilities. Notably, Samuel Ropp was promoted to Chief Commercial Officer in May 2023.
Discover the tools Singular Genomics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Singular Genomics commonly utilizes the email format combining the first initial and last name. Other variations might exist but this is a frequently observed pattern for companies of its type.
[first_initial][last]@singulargenomics.com
Format
dspaventa@singulargenomics.com
Example
85%
Success rate
Business Wire • May 7, 2024
Singular Genomics announced its financial results for Q1 2024, highlighting revenue of $0.8 million, shipment of G4 sequencers, and progress in its commercial and operational strategies....more
Business Wire • February 27, 2024
The company reported its Q4 and full-year 2023 financial results, discussing G4 platform adoption, operational highlights, and its outlook for 2024, including focus on scaling manufacturing and commercialization....more
Business Wire • January 8, 2024
Singular Genomics provided preliminary unaudited revenue for Q4 and full-year 2023, along with updates on G4 shipments and Max Read kits, indicating growing instrument placements and consumables utilization....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Singular Genomics, are just a search away.